OostNL is a development company based in Apeldoorn, Netherlands, dedicated to strengthening the regional economies of Gelderland and Overijssel. Established in 2003, it invests public funds in entrepreneurs across various sectors, including food, energy, health, logistics, and technology. In addition to financial support, OostNL provides knowledge, expertise, and a robust network to facilitate innovation and growth among businesses. The organization emphasizes a balance between financial returns and social impact, aiming to foster sustainable economic development and job creation. By focusing on sustainability, smart industry, and health-related initiatives, OostNL aims to address global social challenges while promoting entrepreneurship and internationalization in the region.
Operator of an employer benefit platform intended for parents at work. The company's platform provides training, coaching and improvement programs which include providing maternal and paternal health and workplace wellbeing services, enabling employers to create a healthy work culture and living.
Glampings.com
Seed Round in 2025
Glampings.com is a prominent European platform that facilitates the search and booking of glamping holidays. It offers a diverse range of accommodations, including luxury safari tents and adventurous tree houses, across multiple countries in Europe. The platform is designed to provide users with a seamless experience, allowing them to easily search, select, and reserve their ideal glamping getaway without incurring any additional reservation fees. Glampings.com aims to enhance the outdoor experience by connecting travelers with unique and comfortable camping options, making it easier for individuals to enjoy nature in a stylish and convenient manner.
AMT Medical
Series B in 2025
AMT Medical B.V., founded in 2015 and based in Ede, the Netherlands, specializes in developing innovative devices for heart bypass surgery. The company has created the AMT Heart Bypass System, which utilizes the ELANA bypass technique, originally developed by neurosurgeon Prof. Dr. C.A.F. Tulleken and his team. This minimal invasive approach aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, ultimately improving patient outcomes and recovery times. The AMT Heart Bypass System has completed its development and production processes, as well as all pre-clinical trials. A clinical multi-center trial is set to begin in late 2019 or early 2020, marking a significant step in bringing this advanced technology to the medical community.
Grassa
Venture Round in 2025
Grassa BV specializes in the valorization of plant-based streams through bioraffinage, focusing on extracting value from grass and other agricultural residues. The company utilizes mobile refining machines to process fresh grass from pastures, agricultural by-products, invasive aquatic plants, and natural grass from conservation areas. This innovative approach yields four key products: fibers, protein, phosphate, and whey (liquid byproduct). Grassa's technology not only enhances the utility of these plant materials but also supports farmers by providing access to advanced solutions that help address food scarcity and improve their income stability.
Cano-ela
Seed Round in 2025
Cano-ela is a food technology company focused on enhancing the food supply chain by eliminating refined ingredients. It specializes in processing oil-rich seeds, such as canola, to extract naturally occurring structures. The firm's innovative approach replaces conventional refined ingredients with mildly refined seed fractions, allowing clients to create natural emulsion-based food products that are environmentally sustainable and feature clean labels. Through its technology, Cano-ela aims to support the development of healthier food options while minimizing the ecological impact of food production.
Mair Therapeutics
Pre Seed Round in 2025
Mair Therapeutics is a biotechnology company focused on developing treatments for neurodegenerative disorders, with a particular emphasis on Parkinson's disease. The company's platform specializes in discovering small-molecule ion channel activators that regulate the lysosomal ion channel TMEM175, controlling lysosomal pH to degrade protein aggregates associated with these conditions. Currently, Mair Therapeutics is in the preclinical drug discovery phase.
OneThird
Series A in 2025
OneThird is a technology company focused on reducing food loss and waste in the supply chain through innovative IoT systems. By utilizing a cloud-based architecture and handheld scanners powered by artificial intelligence, the company enables retailers to assess the quality and shelf life of fresh produce accurately. This technology empowers users to predict how many days remain until food spoilage, enhancing inventory management and ensuring that products are sold at optimal times. OneThird's solutions aim to improve cold chain logistics and contribute to sustainable practices in line with global efforts to minimize food waste.
New Origin
Seed Round in 2025
New Origin operates as a photonic chips foundry to produce silicon nitride chips.
InsectSense
Pre Seed Round in 2025
InsectSense is a biotechnology company that leverages the advanced sensory capabilities of insects to develop innovative solutions for detecting and measuring compounds in low concentrations. By drawing inspiration from insects' evolutionary adaptations, the company aims to create disruptive technologies that address global challenges and generate positive societal and environmental impact. InsectSense's core focus is to enable precise and accurate diagnosis of novel diseases by identifying the unique 'fingerprint' of volatile compounds within complex samples.
Alveron Pharma
Seed Round in 2024
Alveron Pharma is focused on developing innovative treatments for hemorrhagic stroke and various thromboembolic disorders, addressing significant unmet medical needs. The company’s lead product, OKL-1111, is an injection solution designed to reduce hematoma expansion in cases of intracranial hemorrhage, moving away from complex pre-treatment processes. Additionally, Alveron is working on a cyclodextrin-based anticoagulant reversal drug, which aims to provide effective solutions for excessive bleeding related to conditions such as hemophilia, trauma, and surgical procedures. By advancing its coagulation technology, Alveron Pharma strives to enhance therapeutic options for medical practitioners dealing with acute and long-term bleeding complications.
RIFT
Series A in 2024
RIFT is a startup focused on advancing sustainability through clean and renewable energy solutions. The company has developed Iron Fuel Technology, which aims to significantly reduce the global carbon footprint in energy-intensive sectors. This innovative fuel offers a reliable source of fully renewable heat throughout the year, enabling industries with high energy consumption to actively participate in global decarbonization efforts. RIFT's commitment to sustainable practices positions it as a key player in the transition towards a greener future.
NoPalm-Ingredients
Seed Round in 2024
NoPalm Ingredients specializes in the production of sustainable microbial oils that serve as alternatives to palm and other tropical oils in the food and cosmetics industries. By utilizing fermentation technology, the company aims to eliminate the reliance on palm oil, addressing environmental concerns associated with its production. NoPalm Ingredients provides eco-friendly solutions that contribute to the reduction of greenhouse gas emissions and promote decarbonization throughout the value chain. This approach not only helps protect forests and wildlife but also supports healthier options for consumers and benefits local populations.
Hudson River Biotechnology
Venture Round in 2024
Hudson River Biotechnology is a biotech company focused on the genetic optimization of plants to produce high-value compounds for a sustainable bio-economy. The company employs innovative breeding techniques to develop new plant traits, utilizing advanced genetic target identification and nano-delivery technologies. By anticipating the biotechnological needs of a sustainable agri-food supply chain, Hudson River Biotechnology provides solutions that empower clients to address the decline of agrochemical alternatives. Through its efforts, the company aims to contribute significantly to the transition towards more sustainable agricultural practices.
Hexwise
Pre Seed Round in 2024
Hexwise specializes in the optimization of air-cooled heat exchangers to enhance energy efficiency and reduce wastage across various industrial applications. The company develops software that improves the performance and maintenance of heat exchangers used in thermal power plants, gas transport networks, and chemical facilities, among others. Its monitoring system integrates seamlessly with existing heat exchangers, providing maintenance and asset managers with valuable insights and recommendations. By leveraging this technology, Hexwise enables businesses to significantly increase their energy efficiency and operational effectiveness.
Time-Travelling Milkman
Seed Round in 2024
Time-Travelling Milkman specializes in producing plant-based cream derived from sunflower seeds, aimed at creating sustainable dairy alternatives. The company focuses on developing fat ingredients that provide a creamy and flavorful experience while ensuring minimal environmental impact. By utilizing research-based plant materials, Time-Travelling Milkman caters to consumers seeking healthy and appetizing options in dairy substitutes, contributing to a more sustainable food system.
Brilliance
Seed Round in 2023
Brilliance specializes in the development of micro laser modules designed for augmented reality displays. The company has created a visual silicon-nitride-based platform that provides technical advantages and supports high-quality, low-cost volume production. This platform is engineered to deliver advanced light engines for projection applications, particularly in augmented reality. By focusing on laser projection technology, Brilliance aims to address key challenges such as miniaturization, integration, energy efficiency, and user comfort in AR applications.
Scope Biosciences
Seed Round in 2023
Scope Biosciences is a company focused on developing molecular diagnostics utilizing CRISPR-Cas technology. A spin-off from Wageningen University & Research, it aims to provide innovative and accessible testing solutions for infectious diseases and genetic traits. The company's platform features rapid, on-site diagnostic tests that are designed to be sensitive, specific, and affordable. By offering these advanced diagnostic tools, Scope Biosciences enables customers to make informed decisions regarding their health and well-being.
SuperLight Photonics
Seed Round in 2023
SuperLight Photonics is a technology company that specializes in the development of advanced laser systems. Their core product is a supercontinuum generation laser, designed to serve as a versatile light source for various applications, including advanced spectroscopy, biomedical imaging, industrial inspection, and environmental sensing. This laser enables scientists, engineers, and professionals in fields like research and healthcare to study ultrafast molecular processes with high precision.
Tagworks Pharmaceuticals
Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.
Delta Diagnostics
Series A in 2023
Delta Diagnostics, founded in 2018 as a spin-off from TNO – The Netherlands Organisation for Applied Scientific Research, specializes in photonic biosensor technology. The company leverages patented innovations developed in TNO's Optics department to commercialize rapid, sensitive, and low-cost biosensors and instruments. These advanced biosensors utilize integrated photonics and optical chips containing waveguides that facilitate the transportation of light across multiple sensors. This technology enables real-time, label-free monitoring of biomarkers, allowing for accurate concentration measurements within minutes. Delta Diagnostics aims to enhance research in life sciences and facilitate the development of novel diagnostics through its innovative biosensing solutions.
revyve
Series A in 2023
Revyve specializes in producing animal-free food ingredients derived from microorganisms. The company offers a range of premium ingredients, including emulsifiers, heat-set gels, and foaming agents, aimed at creating replacement proteins. Revyve's products serve as egg replacers and are designed to meet specific protein functionality requests from customers. By focusing on natural microorganisms, the company enables the production of great-tasting foods that do not compromise on taste, texture, health, or sustainability.
PEF Technologies
Venture Round in 2023
PEF Technologies specializes in innovative food processing through the use of nanosecond pulsed electric field technology. This non-thermal method offers an alternative to traditional pasteurization, enhancing food and beverage preservation while maintaining flavor and nutritional content. By applying short-duration high-intensity electric fields, the technology not only extends the shelf life of products but also improves the bioaccessibility and bioavailability of their nutritive components. Additionally, PEF Technologies addresses energy consumption concerns in food processing, making it a viable option for clients seeking efficient and sustainable solutions in the industry.
OneThird
Seed Round in 2023
OneThird is a technology company focused on reducing food loss and waste in the supply chain through innovative IoT systems. By utilizing a cloud-based architecture and handheld scanners powered by artificial intelligence, the company enables retailers to assess the quality and shelf life of fresh produce accurately. This technology empowers users to predict how many days remain until food spoilage, enhancing inventory management and ensuring that products are sold at optimal times. OneThird's solutions aim to improve cold chain logistics and contribute to sustainable practices in line with global efforts to minimize food waste.
Pro Parents
Pre Seed Round in 2023
Operator of an employer benefit platform intended for parents at work. The company's platform provides training, coaching and improvement programs which include providing maternal and paternal health and workplace wellbeing services, enabling employers to create a healthy work culture and living.
ArthroSave
Seed Round in 2023
ArthroSave specializes in joint-preserving surgical procedures aimed at younger patients with knee osteoarthritis. The company has developed a medical device that addresses knee injuries and facilitates joint-saving treatments for individuals suffering from significant knee joint damage. This innovative device allows orthopedic surgeons to perform safe and effective knee replacements without disrupting the original alignment of bones and tissues. By focusing on patients under sixty-five years of age, ArthroSave provides a solution that alleviates persistent knee pain while preserving joint function, ultimately enhancing the quality of life for those affected by this condition.
LioniX International
Venture Round in 2023
LioniX International specializes in the development and manufacturing of photonic microsystems, focusing on optical devices and sensors. The company offers customized solutions for original equipment manufacturers and system integrators, guiding clients from design through to fully assembled modules. LioniX International leverages its expertise in Photonic Integrated Circuits (PIC), micro-electromechanical systems (MEMS), and opto-fluidics to deliver scalable production volumes. The company maintains a strong intellectual property position, which underpins its technology leadership in the industry, particularly in providing innovative micro nanotechnology solutions for the telecommunications sector.
Aiosyn
Seed Round in 2022
Aiosyn is a company focused on enhancing diagnostic precision in cancer and chronic kidney diseases through the development of artificial intelligence-driven pathology algorithms. Utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms with existing pathology workflows, thereby streamlining processes for healthcare professionals. The company's platform promotes collaboration between pathologists and AI, facilitating improved decision-making in both clinical diagnostics and drug development. By improving the efficiency of studies for biopharmaceutical companies, Aiosyn aims to enhance the accuracy of diagnoses and ultimately increase the survival rates of patients with cancer and chronic kidney diseases.
SAIA Agrobotics
Seed Round in 2022
Saia Agrobotics is focused on transforming agriculture through advanced robotics, specifically aimed at enhancing food production in greenhouses and indoor farming environments. The company develops autonomous robots designed to automate various tasks in the horticulture sector, including harvesting and crop handling. By utilizing artificial intelligence in their robotic systems, Saia Agrobotics addresses challenges related to climate change and food security, allowing farmers to achieve improved yields with reduced land usage. The company aims to make indoor farming more accessible and affordable, thereby supporting sustainable agricultural practices and ensuring food security in the face of global challenges.
Secret View
Series A in 2022
Secret View is a community platform that enables users to publish assignments and enhance their feedback-giving skills through e-learning, personal support, and quality checks. Additionally, it operates as a market research agency focused on optimizing customer experiences for businesses. By providing an accessible and cost-effective solution, Secret View allows organizations to gather and learn from real customer feedback, particularly through mystery shopping research. This approach helps retail and hospitality chains effectively measure and improve their customer experience.
Enzyre
Series A in 2022
Enzyre is a developer of innovative diagnostic technology aimed at enhancing patient care while controlling healthcare costs. The company has created a point-of-care diagnostic device that specializes in blood coagulation testing, capable of measuring up to twelve reactions using a small volume of blood. This technology allows patients to perform tests in various settings, including at home, while traveling, or in critical care environments, eliminating the need for laboratory infrastructure. By bringing laboratory capabilities directly to the patient, Enzyre seeks to improve the quality of life for individuals requiring regular monitoring of their health.
Fiber Unlimited
Seed Round in 2022
Fiber Unlimited specializes in products and services for indoor Plastic Optical Fiber (POF) networks, focusing on the development of telecom solutions based on optical technology. The company designs in-house products that integrate fiber-access technologies to create a comprehensive managed optical network. This network solution aims to provide a reliable, fast, and sustainable internet connection suitable for both professional and residential use. By enabling efficient communication, Fiber Unlimited addresses the growing demand for high-quality indoor network services.
Borg Energy Storage
Series A in 2022
Borg Energy Storage is focused on developing sustainable thermal energy solutions for residential buildings. The company has created a heat storage system that utilizes solar collectors to heat water during the summer months, which is then stored in a buffer tank located beneath the house or in the garden. This innovative approach allows homeowners to retain and utilize heat during the winter, enhancing energy efficiency. In addition, Borg Energy Storage provides energy management software to optimize energy use, promoting both sustainability and cost savings for users. The company's solutions are designed to improve the overall comfort and energy performance of homes.
Enliven
Venture Round in 2022
You can experience what it's like to be in someone else's shoes with Enliven's virtual reality experiences. a realistic experience that enables you to view the world from a different angle.
Pleco Therapeutics
Series A in 2022
Pleco Therapeutics is focused on developing innovative therapies for cancer, particularly orphan treatments for diseases with limited options. The company is currently engaged in pre-clinical development of its PlecoidTM medications, targeting Acute Myeloid Leukaemia and Small-Cell Lung Cancer, both of which are associated with poor prognoses. Pleco Therapeutics aims to enhance the effectiveness of existing chemotherapy regimens and improve patient outcomes by altering protein expression within the cancer microenvironment and alleviating the burden of toxic metals in cancer cells. Through these efforts, the company seeks to extend patient lifespans and improve their quality of life.
PHIX
Debt Financing in 2022
PHIX is a packaging foundry that supplies the photonics industry with assembly and packaging services. PHIX develops optoelectronic modules on all major PIC technology platforms, including indium phosphide, silicon photonics, silicon nitride, and planar lightwave circuit. PHIX specializes in chip-to-chip hybrid integration, fiber array coupling, and the interfacing of DC and RF electrical signals.
PHIX
Venture Round in 2022
PHIX is a packaging foundry that supplies the photonics industry with assembly and packaging services. PHIX develops optoelectronic modules on all major PIC technology platforms, including indium phosphide, silicon photonics, silicon nitride, and planar lightwave circuit. PHIX specializes in chip-to-chip hybrid integration, fiber array coupling, and the interfacing of DC and RF electrical signals.
QuiX
Seed Round in 2022
QuiX BV, located in Enschede, the Netherlands, specializes in the development of integrated and reconfigurable light-based quantum processors. The company focuses on quantum information processing through its proprietary TriPleX platform, which utilizes stoichiometric Si3N4 waveguides. QuiX offers plug-and-play solutions that enable stable and efficient processing of single photons, facilitating advancements in quantum computing. By providing both integrated photonic processors and customized devices, QuiX aims to contribute significantly to the evolution of quantum technologies, paving the way for a transformative approach to information processing.
Corvus Drones
Seed Round in 2022
Corvus Drones specializes in autonomous drone applications specifically designed for the agricultural sector, including horticulture, crop monitoring, and pest recognition. The company leverages innovative technology to enhance agricultural practices, allowing clients to operate more sustainably while reducing energy consumption, labor, pollution, and costs. Users receive detailed reports on drone findings within an hour, streamlining the decision-making process and minimizing cultivation risks. Through its services, Corvus Drones aims to optimize agricultural production and contribute to a more efficient farming environment. For further inquiries, contact information is available on their website.
Clairify
Seed Round in 2022
Clairify focuses on enhancing tenant-landlord relationships by developing indoor climate measurement sensors that improve air quality and workplace productivity. The company provides insights and suggestions for facility management, contributing to the creation of healthy and energy-efficient work environments. Clairify's technology enables the detection of indoor air quality and comfort data in various settings, including schools and offices. By leveraging predictive analytics, Clairify helps building occupants improve their well-being while simultaneously adding value to properties and reducing maintenance costs. Additionally, the company ensures compliance with indoor air quality regulations, ultimately fostering better tenant experiences.
Pro Parents
Pre Seed Round in 2022
Operator of an employer benefit platform intended for parents at work. The company's platform provides training, coaching and improvement programs which include providing maternal and paternal health and workplace wellbeing services, enabling employers to create a healthy work culture and living.
Aiosyn
Pre Seed Round in 2022
Aiosyn is a company focused on enhancing diagnostic precision in cancer and chronic kidney diseases through the development of artificial intelligence-driven pathology algorithms. Utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms with existing pathology workflows, thereby streamlining processes for healthcare professionals. The company's platform promotes collaboration between pathologists and AI, facilitating improved decision-making in both clinical diagnostics and drug development. By improving the efficiency of studies for biopharmaceutical companies, Aiosyn aims to enhance the accuracy of diagnoses and ultimately increase the survival rates of patients with cancer and chronic kidney diseases.
Prolira BV
Venture Round in 2022
Prolira BV is a Dutch company based in Utrecht that specializes in developing medical technology for the early detection of delirium, an acute brain failure condition. Founded in 2015, Prolira has introduced DeltaScan, an EEG-based device designed to monitor brain activity and facilitate timely treatment for patients at risk of acute encephalopathy and delirium. The DeltaScan system comprises a single-use electrode patch, known as the DeltaScan Patch, and the DeltaScan Monitor, which employs a validated proprietary algorithm to analyze EEG data. This innovative approach aims to enhance patient recovery by supporting clinicians in identifying and addressing delirium, a condition that affects approximately 20 million patients annually in hospitals across Europe and the United States, leading to significant cognitive impairment and increased healthcare costs.
Bilihome B.V.
Seed Round in 2022
Bilihome aims to provide an ordinary-looking romper or vest for newborns, which enables natural care and free bonding during jaundice therapy in the first week of life. The embedded smart wearables and the miniaturized system simplify the logistics and encourage care outside the hospital.
River BioMedics
Seed Round in 2022
River BioMedics is a biotechnology company focused on developing 3D human heart tissue models for pre-clinical drug testing. Recognizing that pharmaceutical companies face significant costs and high failure rates in drug development, particularly due to drug-induced cardiac toxicity, the company aims to enhance drug discovery processes. By creating realistic 3D cardiac tissues that mimic the functioning human heart, River BioMedics provides advanced tools for toxicity screening and target validation. These innovative models offer healthcare professionals valuable insights into the effects of various compounds on cardiac function, thereby facilitating the development of novel cardiac drugs and improving the overall efficiency of drug discovery.
ATRO Medical
Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, focuses on developing innovative solutions for knee joint health through its anatomically shaped meniscus implant, the Trammpolin. This implant is designed to restore the protective function of the meniscus by acting as a joint spacer, thus alleviating pain and improving life quality for patients suffering from osteoarthritis. The company emerged as a spin-out from DSM and Radboudumc, leveraging insights gained from a collaborative initiative that began in 2010, involving various universities and private enterprises with support from the Dutch government. The Trammpolin prosthesis is a synthetic, non-resorbable substitute that mimics the natural meniscus, functioning effectively as a shock absorber by ensuring adequate load distribution within the knee joint.
Fring
Seed Round in 2021
Fring operates a hiring platform designed to streamline the recruitment of freelancers for businesses seeking flexible talent. The platform connects companies with a diverse range of available freelancers, including skilled designers, developers, marketers, and media experts. By providing real-time access to this talent pool, Fring enables organizations to build adaptable teams and efficiently complete project tasks. Additionally, the platform allows freelancers to discover engaging projects, fostering a social connection within the freelance community. Through its innovative approach, Fring aims to redefine how businesses and freelancers collaborate, making the recruitment process more straightforward and effective.
Alveron Pharma
Seed Round in 2021
Alveron Pharma is focused on developing innovative treatments for hemorrhagic stroke and various thromboembolic disorders, addressing significant unmet medical needs. The company’s lead product, OKL-1111, is an injection solution designed to reduce hematoma expansion in cases of intracranial hemorrhage, moving away from complex pre-treatment processes. Additionally, Alveron is working on a cyclodextrin-based anticoagulant reversal drug, which aims to provide effective solutions for excessive bleeding related to conditions such as hemophilia, trauma, and surgical procedures. By advancing its coagulation technology, Alveron Pharma strives to enhance therapeutic options for medical practitioners dealing with acute and long-term bleeding complications.
Xenikos
Convertible Note in 2021
Xenikos is focused on developing innovative immunotherapy treatments aimed at addressing serious immune diseases and complications arising from transplants. The company specializes in anti-T-cell antibodies that can effectively reset the immune system. This therapeutic approach involves injecting a specific agent that targets and eliminates adult T cells, particularly those that are activated, thereby enhancing treatment outcomes for patients. By leveraging this unique mechanism, Xenikos seeks to restore health and improve the quality of life for individuals facing significant immune-related challenges.
ScreenPoint Medical
Series C in 2021
ScreenPoint Medical B.V. is a company based in Nijmegen, the Netherlands, specializing in the development of artificial intelligence software designed to assist radiologists in interpreting digital breast tomosynthesis (DBT) and mammography exams. Founded in 2014, ScreenPoint focuses on creating deep learning and image analysis technologies that enhance the accuracy and consistency of breast cancer detection. By leveraging advanced machine learning techniques alongside extensive, well-curated digital image databases, the company aims to improve the diagnostic process for breast cancer, thereby enabling earlier detection and reducing unnecessary patient recalls. Their flagship product, Transpara, exemplifies this commitment to enhancing clinical outcomes in mammography through innovative technology.
Time-Travelling Milkman
Pre Seed Round in 2021
Time-Travelling Milkman specializes in producing plant-based cream derived from sunflower seeds, aimed at creating sustainable dairy alternatives. The company focuses on developing fat ingredients that provide a creamy and flavorful experience while ensuring minimal environmental impact. By utilizing research-based plant materials, Time-Travelling Milkman caters to consumers seeking healthy and appetizing options in dairy substitutes, contributing to a more sustainable food system.
OneThird
Seed Round in 2021
OneThird is a technology company focused on reducing food loss and waste in the supply chain through innovative IoT systems. By utilizing a cloud-based architecture and handheld scanners powered by artificial intelligence, the company enables retailers to assess the quality and shelf life of fresh produce accurately. This technology empowers users to predict how many days remain until food spoilage, enhancing inventory management and ensuring that products are sold at optimal times. OneThird's solutions aim to improve cold chain logistics and contribute to sustainable practices in line with global efforts to minimize food waste.
Corvus Drones
Seed Round in 2021
Corvus Drones specializes in autonomous drone applications specifically designed for the agricultural sector, including horticulture, crop monitoring, and pest recognition. The company leverages innovative technology to enhance agricultural practices, allowing clients to operate more sustainably while reducing energy consumption, labor, pollution, and costs. Users receive detailed reports on drone findings within an hour, streamlining the decision-making process and minimizing cultivation risks. Through its services, Corvus Drones aims to optimize agricultural production and contribute to a more efficient farming environment. For further inquiries, contact information is available on their website.
PESCHECK
Convertible Note in 2021
Globalization, a hybrid workforce and increasing demand from risk and compliance changed the future of employment rapidly. PESCHECK provides information and insights that make trust possible and ensure that each employee is reliably represented. By creating an actionable and robust picture of each employee. PESCHECK is the all-in-one software designed to accelerate your onboarding process with digital, fast and automated background checks. Creating a user-friendly and secure candidate experience and saves time. #automated background checks #background checks #backgroud screening #background check software #pre employment screening #in employment screening #freelancer screening #backgroud checks API #hrtech #regtech #KYE
InteRNA Technologies
Series B in 2021
InteRNA Technologies B.V. is a biotechnology company focused on the development of microRNA (miRNA)-based therapeutics for cancer treatment. The company's innovative approach leverages the unique properties of miRNAs to target previously undruggable pathways involved in cancer initiation, progression, and metastasis. By utilizing advanced techniques such as massively parallel sequencing and proprietary bioinformatics, InteRNA analyzes and validates miRNA sequences to enhance drug efficacy and reduce resistance to existing therapies. Founded in 2006, the company operates from Nijmegen, the Netherlands, and has a dedicated research and development center in Utrecht. Recently, InteRNA has secured additional equity financing to advance its lead program for melanoma treatment, demonstrating its commitment to developing novel solutions in oncology.
Eurekite
Venture Round in 2021
Eurekite BV, based in Enschede, the Netherlands, specializes in the manufacture of flexible ceramic materials. Established in May 2015 as a spin-off from the University of Twente, the company focuses on the development and commercialization of its innovative technology, known as Flexiramics®. This technology emerged from the Inorganic Materials Science Group of the MESA + Institute for Nanotechnology, led by Professor Andre ten Elshof. Eurekite combines expertise in formulation chemistry, production technology, and composite development, with its disruptive materials attracting investment from prominent venture capital firms.
Pepscope
Venture Round in 2020
Pepscope BV, established in 2012 and headquartered in Nijmegen, the Netherlands, is a biotechnology company specializing in protein kinase activity profiling technologies. It offers QuantaKinome, a solution designed to enhance the discovery and development of novel kinase inhibitors and therapeutic compounds within the pharmaceutical industry and academic research. The company's core services include protein-kinase profiling assays and advanced proteomics services, enabling clients to achieve reproducible results and robust conclusions.
NutriLeads
Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Gatt
Series B in 2020
GATT Technologies BV, established in 2011 and headquartered in Nijmegen, the Netherlands, specializes in developing innovative medical devices. The company focuses on creating synthetic surgical hemostat and sealant products designed to control severe bleeding and organ leakages during surgical procedures. Their product portfolio includes GATT-Patch, a hemostatic sealing patch for general surgery; GATT-Tape, an adhesive tape for preventing intestinal anastomotic leakage; GATT-Spray, an elastic sealant for general surgery; and GATT-Powder, a hemostatic sealing powder. These products are based on a patented synthetic technology, aiming to address challenging surgical bleeding and leakage issues.
Textmetrics
Seed Round in 2019
Textmetrics is a company that offers a content quality platform aimed at enhancing the effectiveness of content delivery for organizations. By leveraging machine learning and artificial intelligence, Textmetrics provides real-time suggestions that help clients create target group-specific content while maintaining corporate consistency. The platform employs scientifically validated algorithms to assist users in crafting engaging and effective text, ultimately enabling organizations to improve conversion rates across both online and offline communications. Through its innovative solutions, Textmetrics supports organizations in making every word count.
PESCHECK
Seed Round in 2019
Globalization, a hybrid workforce and increasing demand from risk and compliance changed the future of employment rapidly. PESCHECK provides information and insights that make trust possible and ensure that each employee is reliably represented. By creating an actionable and robust picture of each employee. PESCHECK is the all-in-one software designed to accelerate your onboarding process with digital, fast and automated background checks. Creating a user-friendly and secure candidate experience and saves time. #automated background checks #background checks #backgroud screening #background check software #pre employment screening #in employment screening #freelancer screening #backgroud checks API #hrtech #regtech #KYE
Prolira BV
Seed Round in 2018
Prolira BV is a Dutch company based in Utrecht that specializes in developing medical technology for the early detection of delirium, an acute brain failure condition. Founded in 2015, Prolira has introduced DeltaScan, an EEG-based device designed to monitor brain activity and facilitate timely treatment for patients at risk of acute encephalopathy and delirium. The DeltaScan system comprises a single-use electrode patch, known as the DeltaScan Patch, and the DeltaScan Monitor, which employs a validated proprietary algorithm to analyze EEG data. This innovative approach aims to enhance patient recovery by supporting clinicians in identifying and addressing delirium, a condition that affects approximately 20 million patients annually in hospitals across Europe and the United States, leading to significant cognitive impairment and increased healthcare costs.
Plasmacure
Seed Round in 2018
Plasmacure is a Netherlands-based company that specializes in developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. Their patented solution effectively kills bacteria, stimulates cell proliferation, and enhances microcirculation, which helps reduce the risk of amputation. By addressing these critical aspects of wound healing, Plasmacure's technology aims to improve the quality of life for patients suffering from chronic wounds.
Mimetas
Series B in 2018
MIMETAS B.V., founded in 2013 and based in Leiden, the Netherlands, specializes in the development of microfluidics-based culture plates designed for the cultivation and screening of three-dimensional organ and tissue models. The company's product line includes OrganoPlate 2-lane and 3-lane systems, which facilitate early-stage screening for drug efficacy and toxic side effects. By addressing the discrepancies between traditional in vitro and animal models and actual patient responses, MIMETAS aims to enhance the predictability of drug testing. Its OrganoPlates enable high-throughput screening of customized disease, toxicology, and transport models, thereby providing researchers and clinicians with innovative tools for compound testing and fundamental research.
SuperBuddy
Venture Round in 2017
SuperBuddy is a Netherlands-based delivery service that specializes in on-demand grocery shopping. The platform acts as an online marketplace, allowing users to conveniently order groceries from local stores. SuperBuddy connects customers with personal shoppers who can accommodate specific requests, ensuring that the desired items are selected. Deliveries are made within a two-hour timeframe, providing users with a quick and efficient way to receive their groceries at home.
SoundEnergy
Venture Round in 2017
SoundEnergy BV is focused on developing and commercializing innovative technologies aimed at reducing fossil energy consumption. The company specializes in Thermo Acoustic Technology, which facilitates zero CO2 climate control in buildings by utilizing heat engines and heat pumps. These products enable cooling and heating without the use of electricity or gas, relying instead on hot water to achieve temperature regulation. SoundEnergy’s approach not only addresses environmental concerns but also aligns scientific advancements with sound business practices, promoting sustainable solutions that benefit both the environment and investors.
Mellon Medical
Series B in 2017
Mellon Medical B.V., established in 2013 and headquartered in Nijmegen, the Netherlands, specializes in the development and marketing of innovative suturing tools designed for surgical applications. The company focuses on creating instruments that enable surgeons to perform single-handed stitching, thereby enhancing the efficiency and effectiveness of suturing tubular and layered structures during medical procedures. By providing advanced suturing solutions, Mellon Medical aims to improve patient outcomes and support medical specialists in delivering high-quality healthcare.
Textmetrics
Seed Round in 2017
Textmetrics is a company that offers a content quality platform aimed at enhancing the effectiveness of content delivery for organizations. By leveraging machine learning and artificial intelligence, Textmetrics provides real-time suggestions that help clients create target group-specific content while maintaining corporate consistency. The platform employs scientifically validated algorithms to assist users in crafting engaging and effective text, ultimately enabling organizations to improve conversion rates across both online and offline communications. Through its innovative solutions, Textmetrics supports organizations in making every word count.
ThermoSmart
Venture Round in 2017
ThermoSmart is a Dutch company that specializes in the development of a user-friendly Wi-Fi thermostat aimed at energy conservation. The thermostat operates independently from energy suppliers and boiler installers, allowing users to manage their home heating efficiently. It can be controlled via an online diary or directly from a smartphone, providing convenience and flexibility. By focusing on ease of use and energy savings, ThermoSmart offers a solution that helps consumers reduce their heating costs while maintaining comfort in their homes.
Xenikos
Series A in 2012
Xenikos is focused on developing innovative immunotherapy treatments aimed at addressing serious immune diseases and complications arising from transplants. The company specializes in anti-T-cell antibodies that can effectively reset the immune system. This therapeutic approach involves injecting a specific agent that targets and eliminates adult T cells, particularly those that are activated, thereby enhancing treatment outcomes for patients. By leveraging this unique mechanism, Xenikos seeks to restore health and improve the quality of life for individuals facing significant immune-related challenges.
ChargeNet
B2B e-truck charging platform
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.